What are the risks and benefits of triple therapy and DAPT for patients with NSTE-ACS?
Triple therapy and DAPT are treatment options for patients with NSTE-ACS which aim to reduce the risk of stent thrombosis, thromboembolic events, and recurrent MI. However, these treatment options also carry a risk of bleeding complications, so it is important to weigh the risks and benefits of each treatment option with the patient before making a decision. It is also important to involve the patient in the decision-making process by discussing the options, advantages, and limitations of the available approaches.